CentralCharts: Supercharge your portfolio with groundbreaking tools.

Subgroup Analysis from Pivotal WU-KONG1B Study Exhibits Robust Efficacy of Sunvozertinib in Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations Across Different Baseline Characteristics PR Newswire SHANGHAI, Sept. 17, 2024 Results of subgroup analysis from the pivotal WU-KONG1B study in relapsed or refractory NSCLC with EGFR exon20ins presented at ESMO 2024 Sunvozertinib demonstrated promising anti-tumor efficacy, regardless of EGFR exon20ins region classification, race,...

Electrolux Group appoints new Head of Investor Relations & Sustainability Reporting PR Newswire STOCKHOLM, Sept. 17, 2024 STOCKHOLM , Sept. 17, 2024 /PRNewswire/ -- Electrolux Group has appointed Ann-Sofi Jönsson as Head of Investor Relations and Sustainability Reporting as from latest February 10, 2025 . Ann-Sofi Jönsson is currently Head of Investor Relations, Group Risk Management and Sustainability at Munters Group AB, and has previously held similar positions within Saab, ABB AG,...

Expansion illustrates Proxymity's efforts to redefine proxy voting, enhancing its capacity to digitise investor relations across the financial ecosystem LONDON, UK / ACCESSWIRE / September 17, 2024 / Proxymity, the leading digital investor communication platform, announced today the successful implementation of Proxymity's Vote Connect Total (VCT) service in the UK and Netherlands by J.P. Morgan. Initially deployed in early 2024 by J.P. Morgan, this is their latest VCT for clients, offering them...

MinervaX and Wacker Biotech Announce Manufacturing Collaboration for Prophylactic Vaccine Targeting Group B Streptococcus PR Newswire COPENHAGEN, Denmark and MUNICH, Sept. 17, 2024 MinervaX scaling up supply of novel GBS vaccine, ahead of phase III studies Wacker Biotech to manufacture active vaccine protein ingredients and prepare for commercial supply after regulatory approval Vaccine to address the unmet medical burden of GBS, both by maternal vaccination to prevent adverse pregnancy outcomes...

Bid date, 2024-09-17 Auction date 2024-09-17 Settlement date 2024-09-18 Maturity Date 2024-09-25 Nominal amount 894 billion SEK Interest rate 3.50 % Bid times 09.30-10.00 (CET/CEST) on the Bid date Bids are made to phone number 08-696 69 70 Confirmation of bids to e-mail [email protected] The lowest accepted bid volume 1 million SEK The highest accepted bid volume 894 billion SEK Allocation Time 10.15 (CET/CEST) on the Bid date Projected minimum liquidity surplus during the term 894 billion SEK...

The SARA-S528NM10, powered by the UBX-S52 cellular/satellite chipset and M10 GNSS platform for low-power and concurrent positioning, expands the company's cellular portfolio for the satellite IoT market based on the 3GPP Rel 17 specification for global connectivity. THALWIL, SWITZERLAND / ACCESSWIRE / September 17, 2024 / u-blox (SIX:UBXN), a global provider of leading positioning and wireless communication technologies and services, has launched its first combined 3GPP-compliant terrestrial...

EQS-News: ELARIS AG / Key word(s): Half Year Results ELARIS AG posts its first positive operating result in the first half of 2024 and grows dynamically 17.09.2024 / 09:14 CET/CEST The issuer is solely responsible for the content of this announcement. ELARIS AG posts its first positive operating result in the first half of 2024 and grows dynamically Sales revenues of EUR 15.1 million during the first half of the year already around 56 percent higher than during the full year 2023 EBITDA turns...